• SENSEX 76,391.39
    -363.66 (--0.47%)
  • BANKNIFTY 56,592.00
    -534.80 (--0.94%)
  • HDFC Bank
    743.25 726.75(%)
  • CIE Automotive
    411.35 382.20(%)
  • Oracle Fin.Serv.
    9,950.00 6,232.20(%)
  • Bluestone Jewel
    732.05 400.40(%)
  • Bharti Airtel
    1,925.60 1,745.00(%)
  • Reliance Industries
    1,268.00 1,253.65(%)
  • Bajaj Finance
    1,037.00 788.40(%)
  • Bajaj Finserv
    1,900.15 2,194.65(%)
  • Tanla Platforms
    656.70 765.75(%)
  • Maruti Suzuki
    13,371.65 12,202.10(%)
  • Gandhar Oil Ref.
    283.85 283.85(%)
  • Route Mobile
    649.90 945.00(%)
  • Eternal
    296.15 368.40(%)
  • Adani Green
    1,372.70 767.00(%)
  • Infosys
    1,032.30 984.00(%)
  • IndusInd Bank
    999.00 710.85(%)
  • SBI
    1,006.50 786.55(%)
  • Axis Bank
    1,219.05 1,041.30(%)
  • CG Power & Ind
    881.00 525.50(%)
  • SBI Funds Mgt.
    575.35 575.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Shilpa Medicare Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5031.0
  • ISIN : INE790G01031
603.60 -10 (-1.59%)
  • As on 24 Jul 2026 (EOD)

  • Today’s Low

    601.00

  • Today’s High

    624.40

  • Open

    609.00

  • Perv Close

    613.35

  • 52W Low

    259.50

  • 52W High

    650.00

Key Indicators

  • P/E(TTM)

    102.06

  • Mar.Cap (₹Cr.)

    11,805.32

  • Div & Yield %

    0.10

  • Book Value(₹)

    138.73

  • Debt-Equity Ratio

    -1.59

  • AGM Date

    23-Jul-2026

  • EPS

    5.91

  • P/E Ratio

    102.06

Financials Ratios

  • Debt-Equity Ratio

    0.48

  • Mar.Cap (₹Cr.)

    11,805.32

  • RONW (%)

    1.72

  • ROCE (%)

    5.16

Score Board

  • Equity (₹ in Cr.)

    19.56

  • BV (₹)

    138.70

  • Sales( ₹ in Cr.)

    597.03

  • NP (in Cr.)

    115.54

  • NP Var(%)

    22.0

  • Div%

    60.0

  • CPS (₹)

    8.70

  • EPS (₹)

    5.90

  • Traded Value (₹ in Lakhs)

    11,796.52

  • 52 Week High

    650.00

  • 52 Week Low

    259.50

  • Price BSE

    603.0

  • Price NSE

    604.00

  • Market Capital( in Cr.)

    11,796.52

  • P/C Ratio

    69.10

  • P/E Ratio

    102.10

  • Price Vs.BV

    5.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 477.34 309.79 247.70 356.95 257.05 805.97
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 477.34 309.79 247.70 356.95 257.05 805.97
Other Income 84.85 89.12 175.32 170.50 204.49 36.79
Stock Adjustments -6.00 -2.63 -4.08 3.18 10.26 14.26
Total Income 556.19 396.28 418.94 530.63 471.80 857.02
EXPENDITURE :            
Raw Materials 114.50 86.62 78.12 81.96 69.37 279.83
Power and Fuel Cost 17.96 18.73 18.70 17.47 12.42 35.31
Employee Cost 99.61 103.64 109.54 110.57 76.10 149.28
Other Manufacturing Expenses 13.24 15.32 18.28 22.79 16.71 35.94
Selling and Administration Expenses 101.45 49.74 60.03 106.22 55.92 67.02
Miscellaneous Expenses 46.72 17.26 18.50 -0.57 3.43 12.50
Employee Benefit Expenses 99.61 103.64 109.54 110.57 76.10 149.28
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 393.49 291.31 303.17 338.44 233.95 579.87
Operating Profit 162.69 104.96 115.78 192.18 237.86 277.15
Interest 6.60 17.26 20.83 9.05 6.07 4.33
Gross Profit 156.09 87.70 94.95 183.13 231.79 272.82
Depreciation 48.86 49.61 46.55 34.82 22.28 34.96
Profit Before Tax 107.23 38.09 48.40 148.31 209.51 237.86
Current Tax 47.08 11.29 -8.37 4.80 15.78 39.09
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -9.64 -0.13 -0.43 2.53 9.34 5.05
Reported Net Profit 69.80 26.94 57.19 140.99 184.39 193.72
Extraordinary Items -25.03 -6.93 -15.86 8.23 46.40 -3.65
Adjusted Net Profit 94.83 33.87 73.05 132.76 137.99 197.37
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 1,359.05 1,332.11 1,284.46 1,152.44 968.05 794.97
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 9.55 8.97 0.00 20.64
P & L Balance carried down 1,428.85 1,359.05 1,332.11 1,284.46 1,152.44 968.05
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 100.00 0.00 0.00 110.00 110.00 110.00
Dividend Per Share(Rs) 1.00 0.00 0.00 1.10 1.10 1.10
Earnings Per Share-Unit Curr 7.14 3.10 6.59 16.24 22.62 23.76
Earnings Per Share(Adj)-Unit Curr 3.57 1.55 3.30 8.12 11.31 11.88
Book Value 276.16 246.85 243.96 237.97 200.89 178.27
Book Value(Adj)-Unit Curr 138.08 123.43 121.99 118.99 100.45 89.14

Shareholding Pattern

  • Promoter Group

    40.13%

  • Public Share Holding

    59.87%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 78,496,648 40.13 78,496,648 21
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 78,496,648 40.13 78,496,648 21
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 1,004 0.00 1,004 2
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 10 0.00 10 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 22,262,432 11.38 22,262,432 108
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,527,562 2.31 4,527,562 1
Mutual Funds / UTI 8,237,418 4.21 8,237,418 11
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,984,817 1.53 2,984,817 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 38,013,243 19.44 38,013,243 132
2] Non Institution
Bodies Corporate 17,183,098 8.79 17,183,098 881
Clearing Members 100,544 0.05 100,544 3
Directors of their Relatives 62,150 0.03 62,150 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 5,223,435 2.67 5,223,435 1,565
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,790,133 0.92 1,790,133 1,492
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 21,960,636 11.23 21,960,636 25
Individuals holding nominal share capital up to Rs. 1 lakh 32,162,127 16.44 32,052,377 56,799
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 68,128 0.03 68,128 4
Others 521,674 0.27 521,674 2
Sub Total 79,071,925 40.43 78,962,175 60,773
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 195,581,816 100.00 195,472,066 60,926

Company Background

Shilpa Medicare LtdPharmaceuticals - Indian - Formulations

  • Shilpa Medicare Ltd
  • BSE Code : 5031.0
  • ISIN : INE790G01031

  • Incorporation Year

    1987

  • Registered Office

    #12-6-214/A1
    Hyderabad Road, Raichur,
    Karnataka-584135

  • Telephone

    91-8532-238704

  • FAX

    91-8532238876

  • Chairman

    Omprakash Inani

  • Managing Director

  • Company Secretary

    Ritu Tiwary

  • Auditor

    B N P S and Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Shilpa Medicare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Shilpa Medicare 603.15 561.18 477.34 88.70 6.20
Abbott India 28,735.45 7,217.19 6,929.05 39.34 43.78
Astrazeneca Phar 7,873.60 2,304.07 2,275.58 104.97 27.86
P & G Health Ltd 6,703.25 944.52 934.17 34.04 71.75
Glaxosmi. Pharma 2,494.20 3,932.76 3,790.20 41.76 58.17
Cipla 1,393.75 20,102.60 18,979.95 32.03 13.88
Amrutanjan Healt 518.15 469.50 451.82 25.87 21.89
Bliss GVS Pharma 462.85 773.53 729.81 50.70 12.51
Fermenta Biotec. 401.95 474.15 450.25 18.40 18.77
Guj. Themis Bio. 355.30 152.47 150.80 83.01 27.21
Ambalal Sarabhai 32.67 19.52 3.94 22.85 6.77